NEWS
SUBSCRIBER SEARCH (Requires Login)
  NEW DRUGS
  MARKETED DRUGS
  COMPANY
  TARGETS IN ONCOLOGY
  NEWS SUMMARIES
  COMBINATION TRIALS

Latest Updates

First Quarter 2010 New Drug Updates and Additions

Designation

Brand Name

Generic Name

 

 

Octreotide

 

 

Talactoferrin alfa, talactoferrin

 

BiovaxID

 

 

Clearazide

Mechlorethamine

 

DCVax-Brain

 

 

Graspa

 

 

Kevetrin

 

 

Lymphoseek

99mTc-DTPA-mannosyl-dextran

 

Multikine

Leukocyte interleukin injection

 

Percutaneous Hepatic Perfusion (PHP)

Doxorubicin

 

Percutaneous Hepatic Perfusion (PHP)

Melphalan

 

Rexonum

Ertumaxomab

 

StemEX

Carlecortemcel-l

 

TNFerade

 

131I-CLR1404, NM404, NM-404

 

 

3PO, PFKFB3

 

 

4-IPP

 

 

ABR-215050

 

Tasquinimod

ABR-217620, TTS CD3

Anyara

Naptumomab estafenatox

ACE-041

 

ACTB1003

 

 

ACTB1010

 

 

ACTB1011

 

 

ADH-1

Exherin

 

ADXS11-001, Lm-LLO-E7

Lovaxin C

 

AEG35156/GEM640

 

 

AEG40826, HGS1029

 

 

ALXN6000

 

 

AMG 479

 

 

AMG-655, AMG655

 

Conatumumab

ANX-514, formerly SDP-014

 

 

ANX-530, formerly SDP-012

Exelbine

Vinorelbine tartrate

AP24534

 

 

APO866, FK866

 

 

APR-246, PRIMA-1MET

 

 

ARQ-650RP, ARQ 650RP, ARQ 197, ARQ197

 

 

AS1409, AS-1409, huBC1-huIL12

 

 

AS1411 (formerly AGRO100, GRO26B-OH)

 

 

ATI-1123-Docetaxel

 

 

AUY922, CCT018159 and related compounds

 

 

AV-299, SCH900105

 

 

AV-951, formerly KRN951

 

Tivozanib

AVR118, AVR 118, OHR118

Formerly Product R or Reticulose

 

AXL1717

 

 

AZD2171, AZD 2171, NSC-732208

Recentin

Cediranib

AZD6244, ARRY-142886, ARRY-886

 

 

BBR 2778

Pixvuri

Pixantrone

BCX-1777

Fodosine

Forodesine hydrochloride

BI-505

 

 

BMS-754807

 

 

BMS753493

Epofolate

 

BN108

 

 

BNP1350

 

Karenitecin

BP-100-1.01, L-Grb2, Grb-2

 

 

BP-100-1.02

 

 

BP-100-2.01

 

 

BSI-201, NSC 746045, SAR240550

 

 

BZL101, BZL 101

Bezielle

 

C2L

 

Octreotide

CAM2032

Prosenze

Leuprolide

CGX-635, NSC-141633

Omapro

Omacetaxine mepesuccinate

CHIR-265, RAF265

 

 

CK37 and analogs

 

 

CMC-544, CMC544, PF-5208773

 

Inotuzumab ozogamicin

COTI-2

 

 

CP-336,156

Fablyn

Lasofoxifene

CP-4126, CO-1.01

 

Gemcitabine 5'-elaidic acid ester

CP-751871, CP-751,871

 

Figitumumab

CPI-613

Thioctan

 

CR011, CR011-vcMMAE

 

Glembatumumab vedotin

CT-011

 

 

CT322, CT-322

Adnectin, Angiocept, formerly TriNectin

 

CUDC-305, CUDC-0305, Debio 0932.

 

 

Cur-691, GDC-0449, RG3616

HhAntag

 

CX-4945/CX-5011

 

 

CYT387

 

 

D-63153, SPI-153

 

Ozarelix

Davanat-1

Pro-5FU

Galactomycin

DI-B4

 

 

DJ-927

 

Tesetaxel

DMXAA, AS1404, AS-1404, ASA404, ASA 404

 

Vadimezan

DOX-LTSL

ThermoDox

Doxorubicin

DOXO-EMCH, INNO-206

 

 

DP-3346/DP-2514

 

 

DPX-0907

 

 

E6201

 

 

E75

NeuVax

 

EC0225

 

 

EC0489

 

 

EC0531, EC0305

 

 

EC0652

 

 

EC145

 

 

EC20

FolateScan

Vitamin folate

EG009, ad.HSV tk

Cerepro

 

ENMD-981693, ENMD-2076

 

 

Eos 200-4, M200, anti-alpha5beta1 integrin

 

Volociximab

ErbituxEDVsPac

 

 

FG-3019

 

 

FP-1039

 

 

FPT069

 

 

G-202

 

 

G207

 

 

GA101, RO5072759, RG7159

GlycoMAb

 

GDC-0879

 

 

GDC-0941 (formerly PI-103, PI103)

 

 

GLPG0187

 

 

GSK1120212

 

 

GSK2118436

 

 

GSK461364

 

 

GVAX pancreatic cancer vaccine

 

 

GW776C85

Cytefuran

Eniluracil

HGS-ETR1, HGS1012, TRM1, TRM-1

 

Mapatumumab

HGS-TR2J, HGS-ETR2, KMTR2

 

Lexatumumab

HuLuc63

 

Elotuzumab

HuM195, SMART M195, SGN-33

Zamyl

Lintuzumab

HuM291

Nuvion

Visilizumab

HuMax-CD4

 

Zanolimumab

huN901-DM1, BB-10901TAP, BB-10901, IMGN901

 

 

HYB2055, IMO-2055, EMD 1201081

IMOxine

 

ICT-107

 

 

ICT-109

 

 

ICT-69

 

 

IMC-1121b, IMC 1121B (previously IMC-1CIIb, IMC-2C6, c-P1C11, IMC-1C11, DC101)

 

Ramucirumab

IMC-11F8

 

Necitumumab

IMC-3G3

 

 

IMC-A12, NSC-742460

 

Cixutumumab

IMC-EB10

 

 

IMMU-103, hLL2, hCD22, AMG 412

LymphoCide

Epratuzumab

IMMU-106, hA20, hCD20

 

Veltuzumab

IMMU-115, hLL1

 

Milatuzumab

INK128

 

 

IPH 1101, BromoHydrin PyroPhosphate (BrHPP)

Phosphostim

 

IPH 2101/NN 1975

 

 

IPI-926

 

 

IRX-2

 

Citoplurikin

KB004

 

 

KW-0761, KM2760

 

 

KXO1, KX01, KX2-391

 

 

L-BLP25, BLP-25 (formerly BP1-7-KLH)

Stimuvax

 

L19-IL2

 

 

LEP-ETU (formerly PNU-93914)

 

Paclitaxel

Liposome Entrapped Docetaxel for Injection (LE-DT)

 

Docetaxel

LMB-2 (formerly anti-Tac(Fv)-PE38), NSC-676422

 

 

LOR-253, ML-220, ML-series (ML-133 and LT-253)

 

 

MB7133, MB07133

 

 

MGN1601

 

 

MGN1703

dSLIM

 

MK2206, MK-2206

 

 

MKC1106-PP, MKC-1106

 

 

MM-121, MM121

 

 

MP-412, AV-412

 

 

MT103, MT-103, MEDI-538

 

Blinatumomab

Mycobacterial Cell Wall-DNA Complex (MCC), MCC/HA

Urocidin

 

NS-187, INNO-406, CNS-9

 

Bafetinib

NVP-HSP990

 

 

NX-473, NX 473 (formerly AMD-473, AMD473, ZD0473)

 

Picoplatin

OMP-21M18

 

 

OSI-027

 

 

OSI-7904L (was GS7904L, GW1843U89, or BW1843U89, or U89), OVI-237

 

 

OSI-906

 

 

OSI-930

 

 

OTS-102, OTS102

 

 

PAT-CM1, CM-1, NM1, PM1

 

 

PAT-LM1, LM-1

 

 

PAT-SM6, SAM-6

 

 

PDL192

 

 

PEG-SN38, EZN-2208

 

 

PF-00562271, PF-562271, PF-562,271

 

 

PLX4032, PLX4720, RG7204, RO5185426

 

 

PLX4032, PLX4720, RG7204, RO5185426

 

 

POL6326

 

 

PR-171

 

Carfilzomib

PRT062607

 

 

PU27

 

 

PX-866, PX866

 

 

PXD101, NSC 726630

 

Belinostat

QbG10, CYT003-QbG10, CYT004-MelQbG10

Immunodrugs

 

R1507, RG1507, formerly Roche 1

 

 

R406/R788, R-788, R935788 sodium

 

Fostamatinib disodium

RX-0201

Archexin

 

RX-3117

 

 

SB485232, SB-485232

 

Iboctadekin

SC-1

 

 

SNS-595, SPC-595 (formerly AG-7352)

 

Voreloxin

STA-9090

 

 

TAK-733

 

 

TAP1, AdhTAP, AdhTAP(OS-1)

 

 

TG20

 

 

TG4010, MVA-MUC-1-IL-2, MVA-MUC1-IL-2

 

 

TH-302, HAP-302

 

 

TL32711

 

 

TLN-4601, ECO-04601, ECO-4601, MW 462

 

 

TRC105, c-SN6j

 

 

TRU-016, CytoxB37G, CD37SMIP

 

 

V158411

 

 

VGX-100

 

 

VGX-200 series

 

 

VM206

 

 

VNP40101M, 101M

Onrigin (formerly Cloretazine)

Laromustine

VQD-002, API-2, NSC-154020, VD-0002

 

Triciribine phosphate (TCN-P), triciribine phosphate monohydrate (TCN-PM)

XL228

 

 

XL281

 

 

XL518, GDC-0973

 

 

XL880, XL-880, GSK1363089, GSK089

 

Foretinib

XmAb 2513

 

 

XmAb 5485, XmAb5485

 

 

XmAb5574

 

 

XRP6258, XRP 6258 (formerly RPR116258, RPR116258A, 116258)

Jevtana

Cabazitaxel

XRP9881, XRP9881A, 109,881 (formerly RPR 109881A, RPR109881, 109881)

 

Larotaxel

ZIO-201, ZIO-201-T

Zymafos

Palifosfamide, isophosphoramide mustard

  

Home   |    Freelance Opportunities   |   New Medicine   |   Site Map   |  Order/Inquiry   
SUBSCRIBER SEARCH:   NEW DRUG   |   MARKETED DRUG   |   COMPANY   |   TARGETS IN ONCOLOGY  

NEW MEDICINE, INC.
P.O. BOX 909, LAKE FOREST, CA 92609
PHONE:  1-949-830-0448     FAX:  1-949-830-0887
INFO@NEWMEDINC.COM